Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase NA 1Phase 4 1Phase 3 1

Status

Completed 20Recruiting 6Active not recruiting 6Unknown 5Terminated 2Not yet recruiting 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 5NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 2Plasma cell 1Lymphoid 1Gastrointestinal 1Dermatologic 1

Conditions

Rectal Neoplasms 1Multiple Myeloma 1Melanoma 1Lymphoma, Mantle-Cell 1Genetic Diseases, Inborn 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

pembrolizumab 198Nivolumab 146Carboplatin 133Specimen Handling 130Magnetic Resonance Spectroscopy 116Cyclophosphamide 112Paclitaxel 106Biopsy 97Cisplatin 94Radiotherapy 89durvalumab 83Dexamethasone 80atezolizumab 73Ipilimumab 66Gemcitabine 60Doxorubicin 60Rituximab 59Lenalidomide 56Docetaxel 55olaparib 51Etoposide 51Bevacizumab 51Fluorouracil 49Capecitabine 49Radiation 47Oxaliplatin 47Radiosurgery 43Prednisone 43venetoclax 41Taxes 41

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Active not recruiting × Tablets × Clear all
NCT04503694 2026-05-22

REGINA

Jules Bordet Institute

Phase 2 Active not recruiting
72 enrolled
Gastrointestinal

Rectal Neoplasms

NCT05392608 2026-05-22

SEQUEL-Breast

Borstkanker Onderzoek Groep

Phase 2 Active not recruiting
130 enrolled
Breast

Breast Neoplasms, Genetic Diseases, Inborn

NCT04802590 2026-05-20

Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma

The Lymphoma Academic Research Organisation

Phase 2 Active not recruiting
210 enrolled
Lymphoid

Lymphoma, Mantle-Cell

NCT06033092 2025-08-28

TOLERANT

European Institute of Oncology

Phase 2 Active not recruiting
200 enrolled
Breast

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

NCT04717700 2025-03-18

SABLe

Odense University Hospital

Phase 2 Active not recruiting
50 enrolled
Plasma cell

Multiple Myeloma

NCT04722575 2025-03-13

NEO-TIM

Fondazione Melanoma Onlus

Phase 2 Active not recruiting
95 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡